Therapy for the treatment of disease

Details for Australian Patent Application No. 2006284940 (hide)

Owner TheraVida, Inc.

Inventors Paborji, Mehdi

Agent Spruson & Ferguson

Pub. Number AU-B-2006284940

PCT Pub. Number WO2007/027675

Priority 60/714,150 02.09.05 US

Filing date 28 August 2006

Wipo publication date 8 March 2007

Acceptance publication date 22 March 2012

International Classifications

A61K 31/4178 (2006.01)

A61K 31/00 (2006.01)

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/216 (2006.01)

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

20 March 2008 PCT application entered the National Phase

  PCT publication WO2007/027675 Priority application(s): WO2007/027675

22 March 2012 Application Accepted

  Published as AU-B-2006284940

19 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006284946-Expandable wave energy conversion system

2006284939-Calculating zernike coefficients from fourier coefficients